Albers DS - Search Results

1

Efficacy of Trabodenoson in a Mouse Keratoconjunctivitis Sicca (KCS) Model for Dry-Eye Syndrome.

Žiniauskaite A, Ragauskas S, Hakkarainen JJ, Rich CC, Baumgartner R, Kalesnykas G, Albers DS, Kaja S. Žiniauskaite A, et al. Among authors: albers ds. Invest Ophthalmol Vis Sci. 2018 Jun 1;59(7):3088-3093. doi: 10.1167/iovs.18-24432. Invest Ophthalmol Vis Sci. 2018. PMID: 30025146

2

Trabodenoson, an Adenosine Mimetic With A1 Receptor Selectivity Lowers Intraocular Pressure by Increasing Conventional Outflow Facility in Mice.

Li G, Torrejon KY, Unser AM, Ahmed F, Navarro ID, Baumgartner RA, Albers DS, Stamer WD. Li G, et al. Among authors: albers ds. Invest Ophthalmol Vis Sci. 2018 Jan 1;59(1):383-392. doi: 10.1167/iovs.17-23212. Invest Ophthalmol Vis Sci. 2018. PMID: 29346804 Free PMC article.

3

Topical Trabodenoson Is Neuroprotective in a Rodent Model of Anterior Ischemic Optic Neuropathy (rNAION).

Guo Y, Mehrabian Z, Johnson MA, Albers DS, Rich CC, Baumgartner RA, Bernstein SL. Guo Y, et al. Among authors: albers ds. Transl Vis Sci Technol. 2019 Dec 20;8(6):47. doi: 10.1167/tvst.8.6.47. eCollection 2019 Nov. Transl Vis Sci Technol. 2019. PMID: 31879569 Free PMC article.

4

Experience with a hybrid recruitment approach of patient-facing web portal screening and subsequent phone and medical record review for a neurosurgical intervention trial for chronic ischemic stroke disability (PISCES III).

Kolls BJ, Muir KW, Savitz SI, Wechsler LR, Pilitsis JG, Rahimi S, Beckman RL, Holmes V, Chen PR, Albers DS, Laskowitz DT. Kolls BJ, et al. Among authors: albers ds. Trials. 2024 Feb 28;25(1):150. doi: 10.1186/s13063-024-07988-z. Trials. 2024. PMID: 38419030 Free PMC article.

5

Attenuation of rotenone toxicity in SY5Y cells by taurine and N-acetyl cysteine alone or in combination.

Alkholifi FK, Albers DS. Alkholifi FK, et al. Among authors: albers ds. Brain Res. 2015 Oct 5;1622:409-13. doi: 10.1016/j.brainres.2015.06.041. Epub 2015 Jul 10. Brain Res. 2015. PMID: 26168893

6

Educational and career goals of pharmacy students upon graduation.

Migliore MM, Costantino RC, Campagna NA Jr, Albers DS. Migliore MM, et al. Among authors: albers ds. Am J Pharm Educ. 2013 Nov 12;77(9):187. doi: 10.5688/ajpe779187. Am J Pharm Educ. 2013. PMID: 24249849 Free PMC article.

7

Matrix metalloproteinase-9 is elevated in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice.

Lorenzl S, Calingasan N, Yang L, Albers DS, Shugama S, Gregorio J, Krell HW, Chirichigno J, Joh T, Beal MF. Lorenzl S, et al. Among authors: albers ds. Neuromolecular Med. 2004;5(2):119-32. doi: 10.1385/NMM:5:2:119. Neuromolecular Med. 2004. PMID: 15075439

8

Elevated levels of matrix metalloproteinases-9 and -1 and of tissue inhibitors of MMPs, TIMP-1 and TIMP-2 in postmortem brain tissue of progressive supranuclear palsy.

Lorenzl S, Albers DS, Chirichigno JW, Augood SJ, Beal MF. Lorenzl S, et al. Among authors: albers ds. J Neurol Sci. 2004 Mar 15;218(1-2):39-45. doi: 10.1016/j.jns.2003.10.015. J Neurol Sci. 2004. PMID: 14759631

9

Minocycline enhances MPTP toxicity to dopaminergic neurons.

Yang L, Sugama S, Chirichigno JW, Gregorio J, Lorenzl S, Shin DH, Browne SE, Shimizu Y, Joh TH, Beal MF, Albers DS. Yang L, et al. Among authors: albers ds. J Neurosci Res. 2003 Oct 15;74(2):278-85. doi: 10.1002/jnr.10709. J Neurosci Res. 2003. PMID: 14515357

10

Dopamine transmission in DYT1 dystonia.

Augood SJ, Hollingsworth Z, Albers DS, Yang L, Leung J, Breakefield XO, Standaert DG. Augood SJ, et al. Among authors: albers ds. Adv Neurol. 2004;94:53-60. Adv Neurol. 2004. PMID: 14509654 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

33 results

Search Page